Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
Leukemia & Lymphoma|June 6, 2013
Inhibition of autophagy augments the anticancer activity of α-mangostin in chronic myeloid leukemia cellsJia-Jie Chen, Zi-Jie Long, Dong-Fan Xu, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|January 2, 2017
Tuberculosis-associated hemophagocytic lymphohistiocytosis in an umbilical cord blood transplant recipientBing Long, Lei Cheng, Shu-Ping Lai, et al.
Oncology Reports|March 10, 2005
Antiproliferation effects of ponicidin on human myeloid leukemia cells in vitroJia-Jun Liu, Ren-Wei Huang, Dong-Jun Lin, et al.
Current Gene Therapy|September 25, 2013
Antibody-directed double suicide gene therapy targeting of MUC1- positive leukemia cells in vitro and in vivoXiao-Ya Dong, Wen-Qian Wang, Yu Zhao, et al.
Cell Biochemistry and Biophysics|August 13, 2011
Inhibition of lymphoma cell proliferation by peroxisomal proliferator-activated receptor-γ ligands via Wnt signaling pathwayJia-Jun Liu, Xue-Jun Dai, Yan Xu, et al.
Molecular Cancer Research : MCR|September 7, 2013
Inhibition of mTOR pathway sensitizes acute myeloid leukemia cells to aurora inhibitors by suppression of glycolytic metabolismLing-Ling Liu, Zi-Jie Long, Le-Xun Wang, et al.
Scientific Reports|November 9, 2016
Aurora A Kinase Inhibitor AKI603 Induces Cellular Senescence in Chronic Myeloid Leukemia Cells Harboring T315I MutationLe-Xun Wang, Jun-Dan Wang, Jia-Jie Chen, et al.
Cell Biochemistry and Biophysics|November 25, 2010
PPARγ agonist suppresses TLR4 expression and TNF-α production in LPS stimulated monocyte leukemia cellsChun-Zhi Wang, Yong Zhang, Xu-Dong Li, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|March 24, 2016
Targeting GLI1 Suppresses Cell Growth and Enhances Chemosensitivity in CD34+ Enriched Acute Myeloid Leukemia Progenitor CellsBing Long, Le-Xun Wang, Fei-Meng Zheng, et al.
Molecular Medicine Reports|August 30, 2017
PIM-1 kinase inhibitor SMI-4a exerts antitumor effects in chronic myeloid leukemia cells by enhancing the activity of glycogen synthase kinase 3βRui-Fang Fan, Ying Lu, Zhi-Gang Fang, et al.
Pageof 5